This thought process may be expounded upon when considering the recent development of targeted molecular therapeutics in the treatment cancer, including PIK3 inhibitors (alpelisib) and PTEN inhibitor, two genes found to have a high prevalence of mutation in sequenced tumor samples.31 Here, PTEN is linked to cancer.